13F

Stock

Keros Therapeutics, Inc.

KROS · held by 1 managers

Reported value

$1.14M

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$512.3K

Price effect on 1 books still in the name

Largest holder

$1.14M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC25K$1.14M−$512.3KCut−$3.47M

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.